KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Vir Biotechnology (VIR) Return on Equity (2019 - 2025)

Historic Return on Equity for Vir Biotechnology (VIR) over the last 7 years, with Q3 2025 value amounting to 0.57%.

  • Vir Biotechnology's Return on Equity fell 1700.0% to 0.57% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.57%, marking a year-over-year decrease of 1700.0%. This contributed to the annual value of 0.38% for FY2024, which is 500.0% down from last year.
  • Latest data reveals that Vir Biotechnology reported Return on Equity of 0.57% as of Q3 2025, which was down 1700.0% from 0.55% recorded in Q2 2025.
  • In the past 5 years, Vir Biotechnology's Return on Equity ranged from a high of 0.71% in Q1 2022 and a low of 0.59% during Q1 2021
  • In the last 5 years, Vir Biotechnology's Return on Equity had a median value of 0.34% in 2024 and averaged 0.14%.
  • Its Return on Equity has fluctuated over the past 5 years, first soared by 13000bps in 2022, then plummeted by -9000bps in 2023.
  • Over the past 5 years, Vir Biotechnology's Return on Equity (Quarter) stood at 0.46% in 2021, then plummeted by -47bps to 0.24% in 2022, then crashed by -254bps to 0.38% in 2023, then dropped by -16bps to 0.44% in 2024, then tumbled by -31bps to 0.57% in 2025.
  • Its last three reported values are 0.57% in Q3 2025, 0.55% for Q2 2025, and 0.53% during Q1 2025.